Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
0419.HK
STRONG SELLREMOVEHony Media Group · Healthcare · Hong Kong · $87M · Avg Vol: $260K/d
Hony Media Group is a small-cap media and healthcare company. It lacks a clear business model, has poor historical ROIC, and lacks any durable economic moat or alignment with our 18-month macro themes, failing all core investment lenses.
COMPANY DESCRIPTION
Hony Media Group provides health information services, digital media production, and online marketing solutions in China. The company's competitive moat is its proprietary digital platforms that deliver specialized health content and targeted medical marketing services to consumers and healthcare providers. It is a niche digital media operator capitalizing on the growing demand for online healthcare information and pharmaceutical marketing.
FINANCIAL SUMMARY
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 202M | 172M | 130M | 73M | -28.8% |
| EPS | -0.03 | -0.01 | -0.02 | -0.01 | — |
| Shares | 1.4B | 1.4B | 1.4B | 1.5B | +9.1% |
| Debt | 7M | 11M | 25M | 19M | 37.2% |
| Equity | 50M | 37M | 13M | 11M | -38.7% |
| Op CF | -12M | -7M | -10M | -7M | — |
| Inv CF | -2M | -3M | 480,880 | 2M | — |
| Fin CF | -1M | 8M | 10M | 4M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 0419.HK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 0419.HK | Hony Media Group(you) | $87M | 17 | STRONG SELL |
| 3681.HK | SinoMab BioScience Limited | $219M | 17 | STRONG SELL |
| 0876.HK | Kaisa Health Group Holdings Limited | $53M | 29 | SELL |
| 0950.HK | Lee's Pharmaceutical Holdings Limited | $80M | 62 | HOLD |
| 0775.HK | CK Life Sciences Int'l., (Holdings) Inc. | $895M | 14 | STRONG SELL |
| 3309.HK | C-MER Medical Holdings Limited | $164M | 70 | BUY |
| 0460.HK | Sihuan Pharmaceutical Holdings Group Ltd. | $1.1B | 32 | SELL |
| 0690.HK | Uni-Bio Science Group Limited | $68M | 92 | STRONG BUY |
| PRE | Prenetics Global Limited | $343M | 73 | BUY |
| 1612.HK | Vincent Medical Holdings Limited | $68M | 99 | STRONG BUY |
Peer medians: ROE 9.0% · P/E 9.2x · Gross margin 41.7%